Biohaven Ltd. Basic Shares Outstanding (Weighted Average)
Biohaven Ltd. (BHVN) reported Basic Shares Outstanding (Weighted Average) of 150.64 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Biohaven Ltd. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 150.64M shares, a 47.15% increase year-over-year.
- Biohaven Ltd. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 147.62M shares, a 44.80% increase year-over-year.
- Biohaven Ltd. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 120.33M shares, a 18.99% increase year-over-year.
- Biohaven Ltd. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 105.82M shares, a 12.13% increase year-over-year.
- Biohaven Ltd. weighted average number of shares outstanding, basic for fiscal 2025 was 107.62M shares, a 17.97% increase from fiscal 2024.
- Biohaven Ltd. weighted average number of shares outstanding, basic for fiscal 2024 was 91.23M shares, a 28.14% increase from fiscal 2023.
- Biohaven Ltd. weighted average number of shares outstanding, basic for fiscal 2023 was 71.20M shares, a 59.14% increase from fiscal 2022.
- Biohaven Ltd. weighted average number of shares outstanding, basic for fiscal 2022 was 44.74M shares, a 13.63% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 150.64M shares 10-Q · filed 2026-08-10 | 149.13M shares 10-Q · filed 2026-08-10 | 139.53M shares derived: average of 3 quarters · filed 2026-08-10 | 131.10M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | 147.62M shares 10-Q · filed 2026-05-04 | 133.97M shares derived: average of 2 quarters · filed 2026-05-04 | 124.59M shares derived: average of 3 quarters · filed 2026-05-04 | 119.03M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | 120.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 113.07M shares derived: average of 2 quarters · filed 2026-03-02 | 109.50M shares derived: average of 3 quarters · filed 2026-08-10 | 107.62M shares 10-K · filed 2026-03-02 | |||
| 2025-09-30 | 105.82M shares 10-Q · filed 2025-11-10 | 104.09M shares derived: average of 2 quarters · filed 2026-08-10 | 103.39M shares 10-Q · filed 2025-11-10 | 102.81M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | 102.37M shares 10-Q · filed 2026-08-10 | 102.16M shares 10-Q · filed 2026-08-10 | 101.81M shares derived: average of 3 quarters · filed 2026-08-10 | 99.95M shares derived: average of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | 101.94M shares 10-Q · filed 2026-05-04 | 101.53M shares derived: average of 2 quarters · filed 2026-05-04 | 99.15M shares derived: average of 3 quarters · filed 2026-05-04 | 96.30M shares derived: average of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | 101.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 97.75M shares derived: average of 2 quarters · filed 2026-03-02 | 94.42M shares derived: average of 3 quarters · filed 2026-03-02 | 91.23M shares 10-K · filed 2026-03-02 | |||
| 2024-09-30 | 94.37M shares 10-Q · filed 2025-11-10 | 91.07M shares derived: average of 2 quarters · filed 2025-11-10 | 87.94M shares 10-Q · filed 2025-11-10 | 85.94M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2024-06-30 | 87.77M shares 10-Q · filed 2025-08-11 | 84.17M shares 10-Q · filed 2025-08-11 | 83.13M shares derived: average of 3 quarters · filed 2026-03-02 | 79.43M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2024-03-31 | 81.60M shares 10-Q · filed 2025-05-12 | 80.81M shares derived: average of 2 quarters · filed 2026-03-02 | 76.65M shares derived: average of 3 quarters · filed 2026-03-02 | 74.55M shares derived: average of 4 quarters · filed 2026-03-02 | |||
| 2023-12-31 | 80.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 74.17M shares derived: average of 2 quarters · filed 2026-03-02 | 72.20M shares derived: average of 3 quarters · filed 2026-03-02 | 71.20M shares 10-K · filed 2026-03-02 | |||
| 2023-09-30 | 68.32M shares 10-Q · filed 2024-11-12 | 68.28M shares derived: average of 2 quarters · filed 2024-11-12 | 68.26M shares 10-Q · filed 2024-11-12 | 66.40M shares derived: average of 4 quarters · filed 2025-03-03 | |||
| 2023-06-30 | 68.25M shares 10-Q · filed 2024-08-09 | 68.23M shares 10-Q · filed 2024-08-09 | 65.76M shares derived: average of 3 quarters · filed 2025-03-03 | 59.17M shares derived: average of 4 quarters · filed 2025-03-03 | |||
| 2023-03-31 | 68.21M shares 10-Q · filed 2024-05-09 | 64.52M shares derived: average of 2 quarters · filed 2025-03-03 | 56.14M shares derived: average of 3 quarters · filed 2025-03-03 | 51.95M shares derived: average of 4 quarters · filed 2025-03-03 | |||
| 2022-12-31 | 60.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 50.11M shares derived: average of 2 quarters · filed 2025-03-03 | 46.53M shares derived: average of 3 quarters · filed 2025-03-03 | 44.74M shares 10-K · filed 2025-03-03 | |||
| 2022-10-02 | 39.38M shares 10-K · filed 2025-03-03 | ||||||
| 2022-09-30 | 39.38M shares 10-Q · filed 2023-11-14 | 39.37M shares 10-Q · filed 2022-11-09 | 39.38M shares derived: average of 2 quarters · filed 2023-11-14 | 39.38M shares 10-Q · filed 2023-11-14 | 39.37M shares 10-Q · filed 2022-11-09 | 39.38M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | 39.38M shares 10-Q · filed 2023-07-31 | 39.38M shares 10-Q · filed 2023-07-31 | 39.38M shares derived: average of 3 quarters · filed 2024-02-29 | 39.38M shares derived: average of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | 39.38M shares 10-Q · filed 2023-05-12 | 39.39M shares derived: average of 2 quarters · filed 2024-02-29 | 39.38M shares derived: average of 3 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | 39.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 39.38M shares derived: average of 2 quarters · filed 2024-02-29 | 39.38M shares 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | 39.37M shares 10-Q · filed 2022-11-09 | 39.37M shares 10-Q · filed 2022-11-09 | |||||
| 2020-12-31 | 39.38M shares 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |